Literature DB >> 7852975

Investigation of cytomegalovirus infection as a risk factor for coronary atherosclerosis in the explanted hearts of patients undergoing heart transplantation.

S Dummer1, A Lee, M K Breinig, R Kormos, M Ho, B Griffith.   

Abstract

Infection with a human herpes virus, particularly cytomegalovirus (CMV), has been hypothesized to be a cofactor in the development of atherosclerosis in humans. We investigated the association of prior CMV infection with the presence of atherosclerosis in the coronary arteries of the native heart of 314 individuals undergoing heart transplantation. Age, male gender, race, tobacco use, and previous general and cardiac surgery were also studied as covariables. Factors associated with the presence of coronary atherosclerosis by univariate analysis were age greater than the median of 48 years (odds ratio [OR] = 5.9, 95% confidence intervals [CI] 3.0-11.6; P < 0.0001), tobacco use (OR = 3.8, 95% CI 2.1-7.0; P < 0.005), CMV seropositivity (OR = 3.1, 95% CI 1.8-5.5; P < 0.001), and male gender (OR = 3.0, 95% CI 1.6-5.4; P < 0.0005). When patients were divided into quartiles based on age, coronary atherosclerosis was shown to be associated with CMV seropositive status only in the youngest quartile of patients (OR = 3.6, 95% CI 1.4-8.9; P < 0.01) but not in the older three quartiles of patients (OR = 0.9, 95% CI = 0.3-2.4; P > 0.5). In multiple logistic regression analyses, CMV seropositivity was not a significant independent variable in the whole group of patients (P = 0.13) but remained a significant variable in the youngest quartile of patients (P = 0.01). However, 43% of these younger patients and 29% of all patients with coronary atherosclerosis were seronegative for CMV.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7852975     DOI: 10.1002/jmv.1890440316

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

1.  Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study.

Authors:  D P Strachan; D Carrington; M A Mendall; B K Butland; P M Sweetnam; P C Elwood
Journal:  Heart       Date:  1999-03       Impact factor: 5.994

2.  Human cytomegalovirus causes endothelial injury through the ataxia telangiectasia mutant and p53 DNA damage signaling pathways.

Authors:  Y H Shen; B Utama; J Wang; M Raveendran; D Senthil; W J Waldman; J D Belcher; G Vercellotti; D Martin; B M Mitchelle; X L Wang
Journal:  Circ Res       Date:  2004-04-22       Impact factor: 17.367

3.  Humoral immune response to human cytomegalovirus in patients undergoing percutaneous transluminal coronary angioplasty.

Authors:  A Tiran; R A Tio; E Oostenveld; M C Harmsen; B Tiran; P Den Heijer; S H Monnink; M M Wilders-Truschnig; T H The
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

4.  MCMV induces neointima in IFN-gammaR-/- mice: intimal cell apoptosis and persistent proliferation of myofibroblasts.

Authors:  D Hamamdzic; R A Harley; D Hazen-Martin; E C LeRoy
Journal:  BMC Musculoskelet Disord       Date:  2001-07-31       Impact factor: 2.362

5.  IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection.

Authors:  Gloria Griffante; Weronika Hewelt-Belka; Camilla Albano; Francesca Gugliesi; Selina Pasquero; Sergio Fernando Castillo Pacheco; Greta Bajetto; Paolo Ettore Porporato; Erica Mina; Marta Vallino; Christian Krapp; Martin Roelsgaard Jakobsen; John Purdy; Jens von Einem; Santo Landolfo; Valentina Dell'Oste; Matteo Biolatti
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

6.  Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels.

Authors:  R M Presti; J L Pollock; A J Dal Canto; A K O'Guin; H W Virgin
Journal:  J Exp Med       Date:  1998-08-03       Impact factor: 14.307

7.  Tuberculosis and Cardiovascular Disease: Linking the Epidemics.

Authors:  Moises A Huaman; David Henson; Eduardo Ticona; Timothy R Sterling; Beth A Garvy
Journal:  Trop Dis Travel Med Vaccines       Date:  2015-10-30

Review 8.  Don't Go Breaking My Heart: MCMV as a Model for HCMV-Associated Cardiovascular Diseases.

Authors:  Cassandra M Bonavita; Rhonda D Cardin
Journal:  Pathogens       Date:  2021-05-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.